CDH2 and ovarian carcinoma: Advanced stages of ovarian cancer involve a mechanism called epithelial mesenchymal transition (EMT) in which epithelial cancer cells lose cytokeratin expression but gain mesenchymal markers such as N-cadherin and vimentin [43]–[45] to facilitate metastasis.